Application of CT-Linac-Based "All-in-One" One-Stop Radiotherapy in Breast Cancer
ConditionBreast Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorFudan University
About this trial
This study aims to evaluate and report the clinical adverse events and dosimetric parameters in breast cancer patients undergoing an "all-in-one (AIO)" one-stop, fully automated radiotherapy workflow. By systematically tracking these clinical and physical metrics, we seek to establish a standardized clinical protocol for AIO radiotherapy in breast cancer management.
Eligibility criteria
Qualifiers
Histologically or pathologically confirmed breast cancer with definitive indications for radiotherapy (preoperative, postoperative, or radical)
ECOG performance status of 0-2
Able to remain still and supine on the treatment couch for up to 30 minutes
Provision of signed, written informed consent
Disqualifiers
Palliative radiotherapy for concurrent distant metastasis
Incomplete or ongoing chemotherapy
Synchronous multiple primary tumors
Current pregnancy or lactation
Trial design
Treatments tested in this trial
- Radiotherapy procedure
Treatment groups
225 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov